Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report)'s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $544.32 and last traded at $544.31, with a volume of 303870 shares changing hands. The stock had previously closed at $536.69.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on ISRG. Barclays boosted their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an "overweight" rating in a research report on Thursday, July 18th. Citigroup upped their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a research note on Thursday, August 22nd. Redburn Atlantic raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Piper Sandler reaffirmed an "overweight" rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $513.74.
Check Out Our Latest Report on ISRG
Intuitive Surgical Trading Up 0.8 %
The stock has a market capitalization of $192.73 billion, a PE ratio of 86.28, a P/E/G ratio of 5.28 and a beta of 1.39. The stock has a 50 day moving average price of $496.95 and a 200-day moving average price of $455.65.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.
Insider Activity
In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Amy L. Ladd sold 450 shares of the firm's stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the business's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock worth $45,897,071 over the last quarter. Insiders own 0.90% of the company's stock.
Institutional Trading of Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Creekmur Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $26,000. Delos Wealth Advisors LLC boosted its stake in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the period. Finally, LRI Investments LLC purchased a new position in Intuitive Surgical in the 1st quarter worth $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
